CODIAK BIOSCIENCES INC (CDAK) Stock Income Statement
NASDAQ:CDAK - Nasdaq - US1920101060 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 34.07M | 22.93M | 2.92M | 390.00K | 0.00 | |||
| Operating Expenses | 82.86M | 92.48M | 93.83M | 80.54M | 38.37M | |||
| Research and Development | 55.31M | 64.86M | 73.98M | 59.50M | 28.47M | |||
| Selling, General, and Administrative Expenses | 27.55M | 27.63M | 19.85M | 21.04M | 9.90M | |||
| Operating Income | -48.80M | -69.55M | -90.92M | -80.15M | -38.37M | |||
| Interest Income/Expense | 280.00K | -2.67M | -1.65M | 1.20M | 1.36M | |||
| Other Income/Expense | 2.32M | 1.78M | 910.00K | 990.00K | 540.00K | |||
| Non Recurring Items | N/A | 33.29M | N/A | 0.00 | -8.07M | |||
| Income Before Taxes | -17.42M | -37.16M | -91.67M | -77.96M | -44.54M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -17.42M | -37.16M | -102.50M | -77.96M | -44.54M | |||
| EBITDA | -44.48M | -64.21M | -86.56M | -77.38M | -36.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.68 | -1.70 | -1.05 | -0.80 | -0.46 | |||
| Non GAAP EPS | -1.99 | -3.21 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -51.13% | -162.01% | -3510.27% | -19989.74% | N/A | |||
| Operating Profit Margin | -143.23% | -303.24% | -3113.70% | -20551.28% | N/A | |||
All data in USD